Acquired <i>RAD51C</i> promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinomaKsenija Nesic(The University of Melbourne)bioRxiv (Cold Spring Harbor Laboratory)December 11, 202010.1101/2020.12.10.419176Cited by 2SaveCiteExport RISWatch citationsRelated Papers<i>BRCA1</i> secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance|medRxiv|2023|8